Anti‐inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy

• Published in: British journal of pharmacology Vol. 118; no. 3; pp. 811 - 819
• Main Authors: Saleh, Tania Silvia Fröde, Calixto, João Batista, Medeiros, Yara Santos
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01-06-1996; Nature Publishing
• Subjects: Albuterol - pharmacology; Animals; anti‐asthmatic drugs; Biological and medical sciences; carrageenin; cromolyn; Cromolyn Sodium - pharmacology; Disease Models, Animal; Dose-Response Relationship, Drug; Female; inflammation; Male; Medical sciences; Mice; Mice, Inbred Strains; Mouse pleurisy; Pharmacology. Drug treatments; Pleurisy - drug therapy; Respiratory system; salbutamol; theophylline; Theophylline - pharmacology; Time Factors; Respiratory disease; Rodentia; Antiinflammatory agent; Antiasthma agent; Vertebrata; Chemotherapy; Mammalia; Treatment; Mouse; Animal; Pleurisy; Theophyllin; Pleural disease; Xanthine derivatives; Comparative study
• ISSN: 0007-1188; 1476-5381
• DOI: 10.1111/j.1476-5381.1996.tb15472.x

1
The aim of this study was to examine the effect of theophylline, cromolyn and salbutamol, three well‐known anti‐asthmatic drugs, on the early (4 h) and late (48 h) phases of cell migration and fluid leakage induced by carrageenin in the pleural cavity of mice.
2
In the first set of experiments, animals were pretreated (30 min) with different doses of theophylline (0.5–50 mg kg−1, i.p.), cromolyn (0.02–0.2 mg per pleural cavity) or salbutamol (0.05–50 mg kg−1, i.p.); the total and differential cell content, and also the exudate were analysed 4 h after carrageenin (1%) administration. Afterwards, in order to evaluate the time course effects of these drugs on both phases of the inflammatory reaction, one dose employed in the above protocol was chosen, to pretreat (0.5–24 h) different groups of animals. The studied parameters were evaluated 4 and 48 h after pleurisy induction.
3
Acute administration of theophylline (1–50 mg kg−1, i.p.), cromolyn (0.02‐0.2 mg per pleural cavity) and salbutamol (0.5–50 mg kg−1, i.p.), 30 min prior to carrageenin, caused significant inhibition of total cell and fluid leakage in the pleural cavity at 4 h (P < 0.01). All drugs exerted a long‐lasting inhibitory effect on both exudation and cell migration (P < 0.01) when administered 0.5–8 h before pleurisy induction. However, the temporal profile of the inhibitory effect induced by these drugs on the first phase of the inflammatory reaction was clearly different. Thus, the inhibitory effect induced by theophylline and cromolyn on exudation was significantly longer (up to 24 h) in comparison to their effects on cell migration (only up to 8 h). In contrast, although salbutamol when administered 30 min before pleurisy induction abolished fluid leakage (P < 0.01), this effect was not sustained in the groups pretreated for 4–8 h. In these latter groups, a significant but much smaller reduction of exudation was observed (P < 0.01), whereas the magnitude of cell migration inhibition did not vary.
4
The second phase (48 h) of the inflammatory reaction induced by carrageenin (1%) was significantly inhibited by cromolyn (0.02 mg per pleural cavity) when this drug was administered 0.5–24 h before pleurisy induction (P < 0.01). Similar results were observed when theophylline (50 mg kg−1, i.p.) was administered 0.5‐4 h before the injection of the phlogistic agent (P < 0.01). Treatment of the animals with salbutamol (5 mg kg−1, i.p.), 0.5–24 h before pleurisy induction, did not inhibit either cell migration or fluid leakage. In this condition, a significant increase of these parameters was observed in the group pretreated with salbutamol 8–24 h before pleurisy induction (P < 0.01).
5
These results indicate that theophylline and cromolyn were able to inhibit the early (4 h) and late (48 h) phases of the inflammatory reaction induced by carrageenin in a murine model of pleurisy. Salbutamol was effective only against the early phase. The inhibitory effects of theophylline, cromolyn and salbutamol on the early phase of this inflammatory reaction were long‐lasting, although a distinct profile of inhibition was observed among them. These findings confirm and extend previous results described in other models of asthma and support both clinical and experimental evidence suggesting that these anti‐asthmatic agents exhibit marked anti‐inflammatory properties.